Live from the NIH registry
Studies recruiting near Rockford right now
Top 25 of 113 recruiting studies, sorted by proximity — each links to its official registry page
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
MercyHealth — Janesville, Wisconsin (29.3 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Carcinoma
Phase 2
Interventional 125 participants sought
Northwestern Medicine: Kishwaukee — DeKalb, Illinois (27.9 mi)
· Sponsor: Northwestern University
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Cutaneous Melanoma, Stage II
N/A
Interventional 2,998 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi)
· Sponsor: Melanoma and Skin Cancer Trials Limited
Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk
Hepatocellular Carcinoma
Phase 2
Interventional 200 participants sought
Northwestern Medicine Kishwaukee Hospital — DeKalb, Illinois (27.9 mi)
· Sponsor: Northwestern University
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
OSF Saint Anthony Medical Center — Rockford, Illinois (1.7 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi)
· Sponsor: National Cancer Institute (NCI)
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
Rectal Cancer
Phase 3
Interventional 250 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi)
· Sponsor: Canadian Cancer Trials Group
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
OSF HealthCare_Cardiovasc Inst — Rockford, Illinois (1.7 mi)
· Sponsor: Novo Nordisk A/S
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Refractory Differentiated Thyroid Gland Carcinoma
Phase 3
Interventional 264 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
Glioblastoma, IDH-Wildtype, MGMT-Unmethylated Glioblastoma
Phase 3
Interventional 398 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi)
· Sponsor: NRG Oncology
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma
Phase 2
Interventional 156 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi)
· Sponsor: National Cancer Institute (NCI)
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma
Phase 3
Interventional 382 participants sought
OSF Saint Anthony Medical Center — Rockford, Illinois (1.7 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm
Phase 2
Interventional 70 participants sought
Mercyhealth Cancer Institute - Rockford — Rockford, Illinois (1.7 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,500 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi)
· Sponsor: NRG Oncology
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8
Phase 3
Interventional 1,978 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 3
Interventional 360 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi)
· Sponsor: National Cancer Institute (NCI)
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8
Phase 3
Interventional 304 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi)
· Sponsor: National Cancer Institute (NCI)
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 1,100 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia
Phase 2
Interventional 93 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi)
· Sponsor: National Cancer Institute (NCI)
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi)
· Sponsor: NRG Oncology
Effectiveness of an Automated Falls-Risk Screening and Referral Tool in the Emergency Department (ED)
Falls-Risk
N/A
Observational 30,000 participants sought
Swedish American Emergency Department — Rockford, Illinois (1.7 mi)
· Sponsor: University of Wisconsin, Madison
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Kidney Disease
Phase 3
Interventional 347 participants sought
Panoramic Health - RNA of Rockford, LLC dba Rockford Nephrology Associates — Rockford, Illinois (1.7 mi)
· Sponsor: Takeda
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Multiple conditions
Phase 3
Interventional 158 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
Locally Advanced Adrenal Cortical Carcinoma, Metastatic Adrenal Cortical Carcinoma
Phase 2
Interventional 48 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi)
· Sponsor: National Cancer Institute (NCI)